Skip to main content

Proceeding contribution from Paul Flynn (Labour) in the House of Commons on Thursday, 8 December 2005. It occurred during Estimates day on Department of Health.


Department of Health

A serious situation has just been revealed in a report by the university of Sussex, which shows that we have been much too ready to license drugs in this country, compared with the United States. Between 1971 and 1992, nine drugs were withdrawn in the United States because they had serious adverse effects, whereas the figure in this country was 24. In our rush to put drugs on to the market for the benefit of the pharmaceutical companies, we are conducting experiments with those drugs and using the public as guinea pigs, and those guinea pigs often do not survive the experiments.


Secondary information

Type
Proceeding contribution
Reference
440 c1024 
Session
2005-06
Chamber / Committee
House of Commons chamber
Subjects
Advertising Licensing Expenditure Drugs Government departments Industry Prescription drugs Department of Health Medicines and Healthcare products Regulatory Agency Research Regulation Safety National Institute for Health and Care Excellence Registration Clinical trials
Link
View this Proceeding contribution on www.publications.parliament.uk